Salvador Escamilla

As a Bothell Fellow, Salvador Escamilla was part of a research team that attempted to better characterize a novel CRISPR edited iPSC line developed in the Mack Lab to model Duchenne Muscular Dystrophy (DMD) in skeletal muscle. Among other findings, immunohistochemistry and a western blot revealed a significant decrease in Fusion Efficiency of myotubes which has been identified as a measure of DMD impact.